Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.

Source:http://linkedlifedata.com/resource/pubmed/id/17121803

Download in:

View as

General Info

PMID
17121803